United Therapeutics Filling $9 Mil. Of Remodulin Orders Following Approval
Executive Summary
United Therapeutics is filling $9 mil. worth of distributors' advance purchase orders for Remodulin following accelerated approval of the drug for treatment of pulmonary hypertension May 21